Jurisdiction | Outcome | Availability | Percentage Change (%) a | |||||||
---|---|---|---|---|---|---|---|---|---|---|
2020 | 2020 vs. 2019 | |||||||||
Q2 vs. Q1 | Q3 vs. Q1 | Q3 vs. Q2 | Q1 | Q2 | Q3 | Q1-Q2 | Q1-Q3 | |||
United States | ||||||||||
Connecticut | Unintentional drug overdose deaths | Q1 2019–Q3 2020 | 25.0 | 18.0 | −5.6 | 23.0 | 23.0 | 1.1 | 23.0 | 14.5 |
Indiana | Drug overdose deaths | Q1 2019–Q2 2020 | 20.6 | – | – | 14.3 | 36.2 | – | 25.3 | – |
Louisiana | Drug overdose deaths | Q1 2019 – Q2 2019; Q1 2020 – Q2 2020 | 32.6 | – | – | 26.9 | 62.2 | – | 44.9 | – |
Maine | Confirmed drug overdose death | Q1 2019–Q2 2020 | 3.1 | – | – | 71.6 | 28.4 | – | 46.6 | – |
Massachusetts | Opioid-related overdose deaths | Q1 2019–Q3 2020 | 17.8 | −14.4 | −27.3 | 1.4 | 19.0 | −14.1 | 10.2 | 2.1 |
Mississippi | Suspected drug overdose deaths | Q1 2019–Q2 2020 | 60.0 | – | – | −41.2 | −18.6 | – | −29.1 | – |
New Hampshire | Confirmed drug overdose deaths | Q1 2019–Q3 2020 | 4.7 | −27.1 | −30.4 | −4.5 | 14.3 | −15.2 | 4.3 | −1.7 |
New Jersey | Suspected drug-related deaths | Q1 2019–Q3 2020 | 2.2 | −8.1 | −10.0 | 19.9 | 14.7 | −11.5 | 17.2 | 6.4 |
Rhode Island | Accidental drug overdose deaths | Q1 2019–Q3 2020 | 5.3 | 11.7 | 6.1 | 22.1 | 25.3 | 41.9 | 23.7 | 29.6 |
Vermont | Opioid-related accidental and undetermined deaths | Q1 2019–Q3 2020 | 25.0 | 28.1 | 2.5 | 6.7 | 122.2 | 20.6 | 50.0 | 37.8 |
Virginia | Drug overdose deaths | Q1 2019–Q2 2020 | 40.3 | – | – | 13.3 | 66.8 | – | 39.4 | – |
Washington | Drug overdose deaths | Q1 2019–Q2 2020 | 12.1 | – | – | 17.7 | 37.2 | – | 27.3 | – |
Canada | ||||||||||
Canada | Apparent opioid toxicity deaths | Q1 2019–Q2 2020 | 58.2 | – | – | −6.4 | 53.7 | – | 23.1 | – |
Alberta | Accidental acute opioid poisoning deaths | Q1 2019–Q3 2020 | 107.3 | 132.7 | 12.2 | −7.4 | 65.4 | 132.7 | 31.7 | 62.0 |
British Columbia | Unintentional illicit drug toxicity deaths | Q1 2019–Q3 2020 | 79.6 | 75.5 | −2.3 | −8.5 | 94.8 | 114.5 | 38.7 | 60.6 |
Quebec | Suspected unintentional opioid or other drug poisoning deaths | Q1 2019–Q3 2020 | 27.6 | 44.0 | 12.8 | −2.5 | 78.3 | 62.1 | 30.7 | 41.3 |